Caricamento...
REDUCED INTENSITY CONDITIONING WITH FLUDARABINE, CYCLOPHOSPHAMIDE, AND HIGH DOSE RITUXAN FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR FOLLICULAR LYMPHOMA: A PHASE II MULTICENTER TRIAL FROM THE BLOOD AND MARROW TRANSPLANT NETWORK (BMT CTN)
Allogeneic hematopoietic cell transplantation (alloHCT) can induce long term remissions in chemosensitive relapsed follicular lymphoma (FL). The BMT CTN conducted a multicenter phase 2 trial to examine the efficacy of alloHCT using reduced intensity conditioning (RIC) with rituximab (RTX) in multipl...
Salvato in:
| Pubblicato in: | Biol Blood Marrow Transplant |
|---|---|
| Autori principali: | , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4949103/ https://ncbi.nlm.nih.gov/pubmed/27118571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.04.014 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|